Oestrogens and the lower urinary tract

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue SUPPL. 1, 2004, Pages 10-14

  Robinson, Dudley ^a   Cardozo, Linda ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; MEDROXYPROGESTERONE; PLACEBO; PROGESTERONE;

AGING; BLADDER CAPACITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGICAL DATA; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; FEMALE GENITAL SYSTEM; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STRESS INCONTINENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URETHRA PRESSURE; URINARY TRACT INFECTION; URINE INCONTINENCE; URODYNAMICS; VAGINA PESSARY; VAGINA RING;

ESTROGENS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; RECURRENCE; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS; URINARY TRACT INFECTIONS;

EID: 10644295767     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00459.x     Document Type: Conference Paper

References (43)

1. Iosif S, Batra S, Ek A, Astedt B. Oestrogens receptors in the human female lower urinary tract. Am J Obstet Gynaecol 1981;141:817-820.
2. Batra SC, Iosif LS. Progesterone receptors in the female urinary tract. J Urol 1987;138:130-134.
3. Iosif C, Bekassy Z. Prevalence of genitourinary symptoms in the late menopause. Acta Obstet Gynaecol Scand 1984;63:257-260.
4. Cardozo LD, Tapp A, Versi E, Samsioe G, Bonne Erickson P, editors. The lower urinary tract in peri- and postmenopausal women. In: The Urogenital Deficiency Syndrome. Bagsverd, Denmark: Novo Industri AS. 1987:10-17.
5. Green S, Walter P, Kumar V, et al. Human oestrogen receptor cDNA sequence, expression and homology to v-erbA. Nature 1986;320:134-139.
6. Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel oestrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-5930.
7. Warner M, Nilsson S, Gustafsson JA. The oestrogen receptor family. Curr Opin Obstet Gynaecol 1999;11:249-254.
8. Rud T, Anderson KE, Asmussen M, et al. Factors maintaining the urethral pressure in women. Invest Urol 1980;17:343-347.
9. Kinn AC, Lindskog M. Oestrogens and phenylpropanolamine in combination for stress incontinence. Urology 1988;32:273-280.
10. Matsubara S, Okada H, Shirakawa Gotoh A, Kuno T, Kamidono S. Oestrogen levels influence beta-3-adrenceptor-mediated relaxation of the female rat detrusor muscle. Urology 2002;59:621-625.
11. Smith PJB. The effect of oestrogens on bladder function in the female. In: Campbell S, editor. The Management of the Menopause and Postmenopausal Years. Carnforth: MTP, 1976:291-298.
12. Samsioe G, Jansson I, Mellstrom D, Svandborg A. Occurance, nature and treatment of urinary incontinence in a 70 year old female population. Maturitas 1985;7:335-342.
13. Hextall A, Bidmead J, Cardozo L, Hooper R. Hormonal influences on the human female lower urinary tract: a prospective evaluation of the effects of the menstrual cycle on symptomatology and the results of urodynamic investigation. Neurourol Urodyn 1999;18:282-283.
14. Van Geelen JM, Doesburg WH, Thomas CMG. Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynaecol 1981;141:384-392.
15. Benness C, Gangar K, Cardozo LD, Cutner A. Do progestogens exacerbate urinary incontinence in women on HRT? Neurourol Urodyn 1991;10:316-318.
16. Elliot RA, Castleden CM. Effect of progestagens and oestrogens on the contractile response of rat detrusor muscle to electrical field stimulation. Clin Sci 1994;87:342.
17. Fantl JA, Cardozo LD, McClish DK, and the Hormones and Urogenital Therapy Committee. Oestrogen therapy in the management of incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynaecol 1994;83:12-18.
18. Zullo MA, Oliva C, Falconi G, Paparella P, Mancuso S. Efficacy of oestrogen therapy in urinary incontinence. A meta-analytic study. Minerva Ginecol 1998;50:199-205.
19. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Synder T. Postmenopausal hormones and incontinence: the Heart and Estrogen/progestin Replacement Study. Obstet Gynaecol 2001;97:116-120.
20. Moeher B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women [Cochrane review]. In: The Cochrane Library, Issue 3. Oxford: Update Software, 2003.
21. Caine M, Raz S. The role of female hormones in stress incontinence. In: Proceedings of the 16th Congress of the International Society of Urology. Amsterdam, the Netherlands.
22. Rud T. The effects of oestrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstet Gynaecol Scand 1980;59:265-270.
23. Wilson PD, Faragher B, Butler B, Bullock D, Robinson EL, Brown ADG. Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. Br J Obstet Gynaecol 1987;94:568-574.
24. Walter S, Wolf H, Barlebo H, Jansen H. Urinary incontinence in postmenopausal women treated with oestrogens: a double-blind clinical trial. J Urol 197833:135-143.
25. Fantl JA, Bump RC, Robinson D, et al. Efficacy of oestrogen supplementation in the treatment of urinary incontinence. Obstet Gynaecol 1996;88:745-749.
26. Jackson S, Shepherd A, Brookes S, Abrams P. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind, placebo controlled trial. Br J Obstet Gynaecol 1999;106:711-718.
27. Sultana CJ, Walters MD. Oestrogen and urinary incontinence in women. Maturitas 1995;20:129-138.
28. Ahmed Al-Badr Ross S, Soroka D, Drutz HP. What is the available evidence for hormone replacement therapy in women with stress urinary incontinence? J Obstet Gynaecol Can 200325:567-574.
29. Samsicoe G, Jansson I, Mellstrom D, Svanberg A. Urinary incontinence in 75 year old women. Effects of oestriol. Acta Obstet Gynaecol Scand 1985;93:57.
30. Cardozo LD, Rekers H, Tapp A, et al. Oestriol in the treatment of post-menopausal urgency: a multicentre study. Maturitas 1993;18:47-53.
31. Nilsson K, Heimer G. Low dose oestradiol in the treatment of urogenital oestrogen defiiciency - a pharmacokinetic and pharmacodynamic study. Maturitas 1992;15:121-127.
32. Benness C, Wise BG, Cutner A, Cardozo LD. Does low dose vaginal oestradiol improve frequency and urgency in postmenopausal women. Int Urogynaecol J 1992;3:281.
33. Eriksen PS, Rasmussen H. Low dose 17β-oestradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynaecol Reprod Biol 1992;44:137-144.
34. Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynaecol 2000;107:1029-1034.
35. Cardozo L, Lose G, McClish D, Versi E. Estrogen treatment for symptoms of an overactive bladder, results of a meta analysis. Int J Urogynaecol 2001;12:V.
36. Brandberg A, Mellstrom D, Samsioe G. Low dose oral oestriol treatment in elderly women with urogenital infections. Acta Obstet Gynaecol Scand 1987;140:33-38.
37. Parsons CL, Schmidt JD. Control of recurrent urinary tract infections in postmenopausal women. J Urol 1982;128:1224-1226.
38. Privette M, Cade R, Peterson J, et al. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988;50:24-27.
39. Kjaergaard B, Walter S, Knudsen A, et al. Treatment with low dose vaginal oestradiol in postmenopausal women. A double blind controlled trial. Ugeskr Laeger 1990;152:658-659.
40. Raz R, Stamm WE. A controlled trial of intravaginal oestriol in postmenopausal women with recurrent urinary tract infections. New Eng J Med 1993;329:753-756.
41. Kirkengen AL, Anderson P, Gjersoe E, et al. Oestriol in the prophylactic treatment of recurrent urinary tract infections in post-menopausal women. Scan J Prim Health Care 1992;10:142.
42. Cardozo LD, Benness C, Abbott D. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 1998;105:403-407.
43. Eriksen B. A randomised, open, parallel-group study on the preventitive effect of an oestradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynaecol 1999;180:1072-1079.